Toxic effects of amantadine in patients with renal failure.
作者信息
Ing T S, Daugirdas J T, Soung L S, Klawans H L, Mahurkar S D, Hayashi J A, Geis W P, Hano J E
出版信息
Can Med Assoc J. 1979 Mar 17;120(6):695-8.
Abstract
摘要
相似文献
1
Toxic effects of amantadine in patients with renal failure.
Can Med Assoc J. 1979 Mar 17;120(6):695-8.
2
Obstructive acute renal failure related to amantadine intoxication.
Am J Emerg Med. 2009 Mar;27(3):371.e5-371.e7. doi: 10.1016/j.ajem.2008.07.020.
3
[Urinary excretion of amylase in patients with renal insufficiency. Correlation with blood amylase, urine creatinine and proteinuria levels].
Rev Esp Enferm Apar Dig. 1984 Jun;65(6):491-7.
4
Increase urinary hepatocyte growth factor excretion in human acute renal failure.
Clin Nephrol. 1997 Oct;48(4):241-5.
5
[Elimination of iodine-containing contrast media during peritoneal dialysis in acute and chronic renal failure].
Z Gesamte Exp Med Einschl Exp Chir. 1970 Aug 23;152(4):325-34.
6
Amantadine-induced serotonin syndrome in a patient with renal failure.
Am J Emerg Med. 2008 Jan;26(1):112.e5-6. doi: 10.1016/j.ajem.2007.07.015.
7
Albuminuria in acute and chronic renal failure.
Acta Med Scand. 1973 Jul-Aug;1-2(1):59-64.
8
[Chronic renal failure diagnosed among patients hospitalised in internal ward in 2004 yuear].
Przegl Lek. 2006;63 Suppl 7:59-61.
9
Acute renal failure in Central Africa. The toxic effects of traditional African medicine.
Cent Afr J Med. 1969 Apr;15(4):71-8.
10
Combination therapy with ribavirin and amantadine in renal transplant patients with chronic hepatitis C virus infection is not superior to ribavirin alone.
J Clin Virol. 2007 May;39(1):54-8. doi: 10.1016/j.jcv.2007.02.006. Epub 2007 Apr 3.
引用本文的文献
1
Amantadine-Induced Craniofacial Myoclonus: Distinctive Iatrogenic Dysarthria in Parkinson's Disease.
Mov Disord Clin Pract. 2023 Jul 14;10(9):1408-1413. doi: 10.1002/mdc3.13828. eCollection 2023 Sep.
2
High dose amantadine therapy may cause increased falling in patients with Parkinson's disease: A case report.
Clin Park Relat Disord. 2020 Feb 22;3:100045. doi: 10.1016/j.prdoa.2020.100045. eCollection 2020.
3
The management of neuroleptic-induced CNS effects.
Can Fam Physician. 1981 Oct;27:1615-24.
4
Control of influenza: when do I use amantadine?
Can Fam Physician. 1989 Oct;35:2115-8.
5
Drug-induced parkinsonism.
Curr Treat Options Neurol. 2009 May;11(3):162-9. doi: 10.1007/s11940-009-0019-3.
6
Treatment of chronic hepatitis C with amantadine.
Dig Dis Sci. 1997 Aug;42(8):1681-7. doi: 10.1023/a:1018857314351.
7
Amantadine and rimantadine prophylaxis of influenza A in nursing homes. A tolerability perspective.
Drugs Aging. 1994 Jul;5(1):8-19. doi: 10.2165/00002512-199405010-00002.
8
Differences in side effects of amantadine hydrochloride and rimantadine hydrochloride relate to differences in pharmacokinetics.
Antimicrob Agents Chemother. 1983 Mar;23(3):458-64. doi: 10.1128/AAC.23.3.458.
9
Amantadine-dyazide interaction.
Can Med Assoc J. 1983 Nov 1;129(9):974-5.
10
Clinical pharmacokinetics of anti-parkinsonian drugs.
Clin Pharmacokinet. 1987 Sep;13(3):141-78. doi: 10.2165/00003088-198713030-00002.
本文引用的文献
1
The toxicologic and pharmacologic properties of amantadine hydrochloride.
Toxicol Appl Pharmacol. 1969 Nov;15(3):642-65. doi: 10.1016/0041-008x(69)90066-0.
2
Absorption, distribution and excretion of amantadine hydrochloride.
J Pharmacol Exp Ther. 1965 Dec;150(3):484-90.
3
Amantadine toxicity in a patient with renal insufficiency.
Nephron. 1974;13(2):183-6. doi: 10.1159/000180391.
4
The chemotherapy of viral infections.
N Engl J Med. 1973 Oct 4;289(14):725-30. doi: 10.1056/NEJM197310042891405.
5
Effect of amantadine on drug-induced parkisonism: relationship between plasma levels and effect.
Br J Clin Pharmacol. 1976 Oct;3(5):883-9. doi: 10.1111/j.1365-2125.1976.tb00642.x.
6
Visual hallucinations and delirium during treatment with amantadine (Symmetrel).
J Am Geriatr Soc. 1975 May;23(5):212-5. doi: 10.1111/j.1532-5415.1975.tb00187.x.
Zotero 插件